Insights

Astrazeneca

Nasdaq Stockholm · LEI PY6ZZQWO2IZFZC3IOL08· Fiscal year 2025

Staff cost per employee
Not disclosed
Employees
Not disclosed

Quick read

  • Revenue grew 8.6% year over year.
  • Revenue has grown two years in a row.
  • Operating margin was 23.4% in 2025.

Last 3 years

Revenue
$45.8B2023$54.1B2024$58.7B2025
Operating income
$8.2B2023$10.0B2024$13.7B2025

See the share price on Google Finance ↗

Investor metrics

2025
Operating margin
23.4%
Net margin
17.4%
ROE
21.0%
Debt-to-equity
134.3%
Equity ratio
42.7%

Staff costs from the annual report (wages, social charges, pensions) divided by the average number of employees. Usually higher than take-home pay.

audited consolidated financial statements · View the annual report (filings.xbrl.org)

Not investment advice. Figures come from public filings and may contain errors.